


Wolverine 32mg TB-500 + BPC-157
Wolverine is an investigational peptide blend containing TB-500 16mg and BPC-157 16mg. Both compounds are being researched for their potential roles in tissue-repair, cellular signalling and recovery-related pathways, with current evidence consisting largely of...
Wolverine is an investigational peptide blend containing TB-500 16mg and BPC-157 16mg. Both compounds are being researched for their potential roles in tissue-repair, cellular signalling and recovery-related pathways, with current evidence consisting largely of preclinical research.
Research areas include: tissue-repair pathways, wound-healing research, cellular migration, inflammation-related pathways, tendon and connective-tissue research, and musculoskeletal recovery research.
Important: Wolverine is an investigational peptide blend and is not approved for general human use. Human clinical evidence for the combination is currently very limited, and research on TB-500 should not be treated as equivalent to research on full-length thymosin beta-4. This product is provided for research purposes only and is not intended to diagnose, treat, cure or prevent any disease or medical condition.
| Form | Lyophilised powder |
| Purity (HPLC) | 99%+ |
| Appearance | White lyophilised solid |
| Solubility | Bacteriostatic / sterile water |
| Storage | Lyophilised at -20°C, reconstituted at 2 to 8°C |
The Certificate of Analysis for lot GX-2026 confirms an HPLC purity of 99%+ and identity confirmed by mass spectrometry.
View in COA libraryThe Safety Data Sheet describes handling, storage and disposal information for this research compound. Always follow standard laboratory safety practice.
View in SDS libraryMore like this


CJC-1295 (No DAC) 9mg + Ipamorelin 9mg

SS-31 60mg Elamipretide

Retatrutide 30mg + GHK-Cu 50mg
Join the research list.
New compounds, batch releases and COA drops, sent before they hit the catalogue.